DEFINITIVEPROXY2005

Company

Ernexa Therapeutics Inc.

Filed

May 5, 2005

Period of Report

May 3, 2005

Accession Number

0000748592-05-000005

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →